 |
Top Story
What Can Pharma Boards Do in the Era of Hostile Takeovers?
With 2015 already a ‘record year for mega-deals’ and on track to be one of the biggest years ever for M&A, another trend is also developing: a growth in hostile takeover bids. In the US, hostile takeovers in the healthcare sector have hit a post-financial crisis high. Mike Straw asks, what can pharma boards do about it?
...Read more |
 |
Regulatory
FDA Slow to Tackle Free Speech Challenges
After months of anticipation, pharma marketers continue to wait for FDA to address options for updating its policies governing sponsor communications involving unapproved drug uses. FDA officials said more than a year ago that they would hold a public meeting to discuss agency policy related to industry “speech” on regulated products. That event now appears on hold, writes Jill Wechsler
...Read more |
 |
Event
CPhI Experts Highlight Importance of Access to Generics, Biosimilars
An expert panel at CPhI Worldwide in Madrid, Spain, last week stressed the continuing importance of emerging market access to generics and biosimilars, but noted the industry’s disappointment with the outcome of the recent TTIP talks
...Read more |
ZS 2015 sales rep compensation study reveals three new trends in pharma
 Learn more
|
Special Feature
Rita Hayworth and Alzheimer’s Redemption
With next month designated National Alzheimer’s Disease and Awareness Month in the US, Julian Upton looks at the film star whose plight pushed the long-misunderstood disorder into the spotlight
...Read more |
Pharmaceutical Executive E-Book – Coming November 2015: Securing the Global Supply Chain: Strategies for Operational Excellence
Key Topics include:
- Compliance Groundswell: What are the New Rules and Regulator Expectations?
- Global Dynamics of Risk: Can Technology Keep Pace?
- Benchmarking Best Practices: Upgrading Company Performance Culture
- What's Ahead: How Logistics and Distribution Science will Shape Tomorrow's Supply Chain
 Contact your sales rep for more information and to secure your sponsorship. |
Comment
Hillary’s History on Rx Price Controls
We may think we know all about Senator Clinton’s view on drug and price controls, but to figure out when and how she arrived at her current position, Tom Norton looks at how her stance has evolved over the last 22 years
...Read more |
U.S. Market Access
Key Learnings from a recent success story
Live Webinar: Thursday, November 19th, 2015 at 11 AM EST
Join Randolph Carpio from Quintiles, and Joe Bonaccorso from Pierre Fabre as they discuss the importance of getting the reimbursement, access and distribution strategy correct to make the most of the opportunities in the U.S.
 Register for free Webinar
|
 |
 | //Crown Bioscience (Santa Clara, CA) named Tetsuya Totsuka, Ph.D., as Manager of Business Development for Japan and Mayet Pantastico as Director of Business development for Australia, Singapore, New Zealand and Korea.//Checkpoint Therapeutics (New York, NY) named James F. Oliviero, III, as President and Chief Executive Officer (CEO).//REGENXBIO (Rockville, MD) appointed David C. Stump, M.D., to its Board of Directors.// |
|
How intelligent is your multichannel strategy?
Live webinar: Wed., Nov. 4, 2015 at 11:00 AM EST
Join Drew Romes and Kyu Om from Quintiles, as the key steps to enable a successful implementation of truly integrated multichannel engagement programs as part of your marketing activities.
 Register for free
|
|
Ready, Set, Launch!
Launch Planning Insights
LIVE WEBCAST: Thursday, October 29, 2015 at 11 am EST
 Register for free
|
